Leadership
;
About
Collaboration is a key value at the heart of OICR.
Collaboration is an integral driver of our leadership team, which brings together experts with diverse voices, backgrounds and skill sets to lead our shared pursuit of world-class translational cancer research together. OICR is overseen by a volunteer Board of Directors, which is responsible for the success and sustainability of the Institute and the overall governance of the affairs of the corporation.
Executive
Laszlo Radvanyi, PhD
President and Scientific Director
Christine Williams, PhD
Executive Vice President, Head of Implementation Science
Lincoln Stein, MD, PhD
Head, Adaptive Oncology
Rima Al-awar, PhD
Head, Therapeutic Innovation and Drug Discovery
Steven Gallinger, MD, MSc, FRCSC
Head, Clinical Translation and Co-Lead, PanCuRx
Jeanette Dias D’Souza, CPA, CA, ICD.D
Senior Vice President, Corporate Services and Group Chief Financial Officer of OICR and FACIT
Board of Directors
Susan Fitzpatrick (Chair)
Head Canadian Drug Agency Transition Office at Health Canada
Jason Berman, MD
Chief Executive Officer and Scientific Director, Children’s Hospital of Eastern Ontario (CHEO); Research Institute and Vice President Research, CHEO
Malcolm Campbell, PhD
Vice-President, Research, University of Guelph
Rodney Cheung, P. Eng, EMBA
Global Chief Information Officer (CIO), BGIS
Janice Deakin, PhD
President and CEO, Higher Education Quality Council
Kevin Empey, CPA
Former President and Chief Executive Officer, Lakeridge Health
Jonathan Irish MD M.Sc. FRCSC FACS
Provincial Head, Surgical Oncology, Cancer Care Ontario/Ontario Health
Wendy Kelley, JD
Chief Legal Officer, People Corporation
Ken Lawless, MSc
President and Chief Executive Officer, Epitope Capital Corp.
Anne-Marie Mes-Masson, PhD
Professor at the Faculty of Medicine of the University of Montreal, Deputy Scientific Director, Basic and Translational Research at the Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM).
Ken Newport, CPA
Chair, BioCanRx
Andrea Redway, LLB
Patient Representative
Geoffrey Porter, MD
Professor of Surgery, Ramia Chair in Surgical Oncology, Dalhousie University
Dawn Powell, MSc
President, Dawn M. Powell Appraisals
Bradly G. Wouters, PhD
Executive Vice President, Science and Research, University Health Network
Scientific Advisory Board
Todd R. Golub, MD (Co-chair)
- Core Institute Member, Chief Scientific Officer and Director of the Cancer Program, Broad Institute
Richard L. Schilsky, MD, FASCO (Co-chair)
- Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology
François Bénard, MD
- Professor and BC Leadership Chair in Functional Cancer Imaging, Department of Radiology, University of British Columbia
- Vice President Research, BC Cancer Agency
Ewan Birney, PhD
- Director and Joint Head of Research and Senior Scientist, European Bioinformatics Institute (EMBL-EBI)
Hakim Djaballah, PhD
- President and CEO, Keren Therapeutics
Sylvia K. Plevritis, PhD
- Professor and Chair, Department of Biomedical Data Science
Elaine R. Mardis, PhD
- Nationwide Foundation Endowed Chair in Genomic Medicine
- Co-Executive Director, Institute for Genomic Medicine, Nationwide Children’s Hospital
- Professor of Pediatrics, The Ohio State University College of Medicine
Deborah Schrag, MD, MPH
- Chief, Division of Population Sciences, Dana Farber Cancer Institute
- Professor of Medicine, Harvard Medical School
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.